Press release
Investigation announced for Investors in Aquestive Therapeutics, Inc. (NASDAQ: AQST) over potential Wrongdoing
An investigation on behalf of investors in Aquestive Therapeutics, Inc. (NASDAQ: AQST) shares over potential wrongdoing.
Investors who purchased shares of Aquestive Therapeutics, Inc. (NASDAQ: AQST) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Aquestive Therapeutics, Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders.
On March 1, 2021, a lawsuit was filed against Aquestive Therapeutics, Inc. over alleged violations of Federal Securities Laws. The plaintiff claims that between December 2, 2019 and September 25, 2020, the Defendants made materially false and misleading statements regarding the Company's business, operational and compliance policies. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that data included in the Libervant NDA submission showed a lower drug exposure level than desired for certain weight groups, that the foregoing significantly decreased the Libervant NDA's approval prospects, that as a result, it was foreseeable that the FDA would not approve the Libervant NDA in its current form, and that as a result, the Company's public statements were materially false and misleading at all relevant times.
On June 25, 2021, an amended complaint was filed and on August 16, 2021, the defendants filed their motion to dismiss the case.
Those who purchased shares of Aquestive Therapeutics, Inc. (NASDAQ: AQST) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Investors in Aquestive Therapeutics, Inc. (NASDAQ: AQST) over potential Wrongdoing here
News-ID: 2746595 • Views: …
More Releases from Shareholders Foundation
ALERT: Lawsuit filed for Investors who SOLD shares of Sina Corporation (formerly …
An investor, who sold shares of Sina Corporation (formerly NASDAQ: SINA) in the merger between Seina Corporation and TuSimple Holdings, Inc, filed a lawsuit over alleged violations of Federal Securities Laws by Sina Corporation (formerly NASDAQ: SINA in connection with certain allegedly false and misleading statements made.
If you sold a significant amount of shares of Sina Corporation (formerly NASDAQ: SINA) between October 13, 2020 and March 22, 2021, you have…
Lawsuit Alert: Investors who lost money with shares of Fluor Corporation (NYSE: …
An investor, who purchased shares of Fluor Corporation (NYSE: FLR), filed a lawsuit alleged violations of Federal Securities Laws by Fluor Corporation in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Fluor Corporation (NYSE: FLR) have certain options and for certain investors are short and strict deadlines running. Deadline: November 14, 2025. NYSE: FLR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779…
Investigation announced for Long-Term Investors in shares of Sable Offshore Corp …
An investigation was announced for long-term investors in shares of Sable Offshore Corp. (NYSE: SOC) concerning potential breaches of fiduciary duties by certain directors of Sable Offshore Corp.
Investors who are current long term investors in Sable Offshore Corp. (NYSE: SOC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in…
Lawsuit filed for Investors who lost money with shares of Lantheus Holdings, Inc …
An investor, who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH), filed a lawsuit over alleged violations of Federal Securities Laws by Lantheus Holdings, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) have certain options and for certain investors are short and strict deadlines running. Deadline: November 10, 2025. NASDAQ: LNTH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
More Releases for Aquestive
Thin Film Drugs Market to See Booming Business Sentiments| Aquestive Therapeutic …
A Latest intelligence report published by MR Forecast with title "Global Thin Film Drugs Market Outlook to 2032. A detailed study accumulated to offer Latest insights about acute features of the Thin Film Drugs market. This report provides a detailed overview of key factors in the Global Thin Film Drugs Market and factors such as driver, restraint, past and current trends, regulatory scenarios and technology development. Some of the Major…
Global Oral Films Market Size,Share, Research and Forecast,2022| Aquestive Thera …
Los Angeles, United States November 2022,- The research study presented here is a brilliant compilation of different types of analysis of critical aspects of the global Oral Films market. It sheds light on how the global Oral Films market is expected to grow during the course of the forecast period. With SWOT analysis and Porter's Five Forces analysis, it gives a deep explanation of the strengths and weaknesses of the global…
Aquestive Therapeutics, Inc. (NASDAQ: AQST) Investor Notice: Update in Lawsuit a …
The Shareholders Foundation announced an update in the lawsuit that is pending for certain investors in Aquestive Therapeutics, Inc. (NASDAQ: AQST).
If you purchased shares of Aquestive Therapeutics, Inc. (NASDAQ: AQST), you have certain options and you should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
On March 1, 2021, a lawsuit was filed against Aquestive Therapeutics, Inc. over alleged violations of Federal Securities Laws. The plaintiff claims…
Investigation announced for Long-Term Investors in shares of Aquestive Therapeut …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Aquestive Therapeutics, Inc.
Investors who purchased shares of Aquestive Therapeutics, Inc. (NASDAQ: AQST) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Aquestive Therapeutics, Inc. (NASDAQ: AQST officers and directors breached their fiduciary duties and caused damage to the…
Aquestive Therapeutics, Inc. (NASDAQ: AQST) Investor Notice: Update in Lawsuit
The Shareholders Foundation announced an update in the lawsuit that is pending for certain investors in , shares of Aquestive Therapeutics, Inc. (NASDAQ: AQST over alleged violations of Federal Securities Laws by Aquestive Therapeutics, Inc.
If you purchased shares of Aquestive Therapeutics, Inc. (NASDAQ: AQST), you have certain options and you should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
On March 1, 2021, a lawsuit was filed…
Investigation announced for Long-Term Investors in Aquestive Therapeutics, Inc. …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Aquestive Therapeutics, Inc..
Investors who are current long term investors in Aquestive Therapeutics, Inc. (NASDAQ: AQST) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: AQST stocks follows a lawsuit filed against…
